Addex Reports 2017 Full Year Results and Provides Corporate Update

Addex Sucessfully Raises CHF40 million in Capital Increase

Swiss Takeover Board Validates New Article 39 (Opting-Out Provision) of Addex Articles of Association

Addex Shareholders Approved all Board Proposals at Extraordinary General Meeting

Addex Secures Investor Commitment for CHF40 million Capital Increase Following Successful Completion of Book Building Process

Addex Publishes Extraordinary General Meeting Invitation

Addex Launches CHF40 million Capital Increase with Commitments from Specialist US Healthcare Investors

Addex Appoints Jean-Philippe Rocher as Co-Head of Discovery and Member of the Executive Management

Addex Provides Key Financial Indicators and Trading Update

Van Leeuwenhoeck Issues Equity Research Note Highlighting Value of Recent Indivior Strategic Partnership on GABAB PAM